Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at ...

Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of ...

A new study has identified a critical mechanism that could lead to substantial advancements in the treatment of acute myeloid ...

Acute myeloid leukemia (AML) is a highly aggressive and difficult-to-treat blood cancer. This study explores the role of ...

PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...

Aymarans, who live in the Andes mountain range of western South America, have evolved their own unique adaptation to life at ...

The race is on be­tween Ku­ra On­col­o­gy and Syn­dax Phar­ma­ceu­ti­cals. On Wednes­day, Ku­ra and its part­ner Ky­owa Kirin an­nounced that their tar­get­ed treat­ment ziftomen ...

Here, we report that PPAR-γ is not essential for the development of the macrophage lineage in vitro and in vivo, but is an important regulator of macrophage gene expression. The scavenger ...

The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now! As a mother to 5-year-old Gene, whom she shares with husband Chris Fischer, 45, Schumer says their kid is already ...